Hyejee Ohm, Shaun M. Goodyear, Zahi Ibrahim Mitri. "A phase 1 study of abemaciclib and niraparib as neoadjuvant therapy in hormone receptor positive and HER2 negative breast cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e12598